Anthrax
FDA Approves Ciprofloxacin for Post-Exposure Use
Published in Medical Letter on the CDC and FDA, September 17th, 2000
This type of exposure would most likely occur during a bioterrorist attack. This indication was granted under provisions of accelerated approval, on the basis of blood levels achieved in humans and the results of in vitro and animal testing.
Since its introduction in 1987, Cipro, made by Bayer Corp., has been extensively studied and is the most widely used fluoroquinolone antibiotic in the world. It has a proven track record of efficacy and safety and has been prescribed more than 250 million times. Cipro is now approved for 14...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Canine Leishmaniasis
Cases Confirmed in 21 States - Diabetes
Sharp Increase in U.S. in 1990s Related to Americans' Weight Gain - Lassa Fever
CDC Study Reports Genetic Variation in Lassa Virus Strains - Prisons
Study: Screening Would Detect Most Inmates with Hepatitis C - Exercise
Researchers Say Lack of Physical Education is Harming Kids - Food Safety
Water Alone Prevents Transfer of Hepatitis A to Lettuce in Canadian Study - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
